181 related articles for article (PubMed ID: 9199570)
1. Lysinuric protein intolerance (LPI) gene maps to the long arm of chromosome 14.
Lauteala T; Sistonen P; Savontaus ML; Mykkänen J; Simell J; Lukkarinen M; Simell O; Aula P
Am J Hum Genet; 1997 Jun; 60(6):1479-86. PubMed ID: 9199570
[TBL] [Abstract][Full Text] [Related]
2. Genetic homogeneity of lysinuric protein intolerance.
Lauteala T; Mykkänen J; Sperandeo MP; Gasparini P; Savontaus ML; Simell O; Andria G; Sebastio G; Aula P
Eur J Hum Genet; 1998; 6(6):612-5. PubMed ID: 9887380
[TBL] [Abstract][Full Text] [Related]
3. Feasibility of prenatal diagnosis of lysinuric protein intolerance by linkage analysis: a case report.
Sperandeo MP; Buoninconti A; Passariello A; Scala I; Adami A; Lauteala T; Mykkänen J; Andria G; Sebastio G
Prenat Diagn; 1999 Aug; 19(8):771-3. PubMed ID: 10451527
[TBL] [Abstract][Full Text] [Related]
4. Characterization of the lysinuric protein intolerance (LPI) region within T-cell receptor alpha/delta gene cluster on chromosome site 14q11.
Lauteala T; Mykkänen J; Horelli-Kuitunen N; Aaltonen J; Paavola P; Savontaus ML; Simell O; Aula P
Hereditas; 1999; 130(1):19-24. PubMed ID: 10364825
[TBL] [Abstract][Full Text] [Related]
5. Human cationic amino acid transporter gene hCAT-2 is assigned to 8p22 but is not the causative gene in lysinuric protein intolerance.
Lauteala T; Horelli-Kuitunen N; Closs E; Savontaus MI; Lukkarinen M; Simell O; Cunningham J; Palotie A; Aula P
Hum Genet; 1997 Jul; 100(1):80-3. PubMed ID: 9225973
[TBL] [Abstract][Full Text] [Related]
6. Functional analysis of novel mutations in y(+)LAT-1 amino acid transporter gene causing lysinuric protein intolerance (LPI).
Mykkänen J; Torrents D; Pineda M; Camps M; Yoldi ME; Horelli-Kuitunen N; Huoponen K; Heinonen M; Oksanen J; Simell O; Savontaus ML; Zorzano A; Palacín M; Aula P
Hum Mol Genet; 2000 Feb; 9(3):431-8. PubMed ID: 10655553
[TBL] [Abstract][Full Text] [Related]
7. A cluster of lysinuric protein intolerance (LPI) patients in a northern part of Iwate, Japan due to a founder effect. The Mass Screening Group.
Koizumi A; Shoji Y; Nozaki J; Noguchi A; E X; Dakeishi M; Ohura T; Tsuyoshi K; Yasuhiko W; Manabe M; Takasago Y; Takada G
Hum Mutat; 2000 Sep; 16(3):270-1. PubMed ID: 10980538
[TBL] [Abstract][Full Text] [Related]
8. SLC7A7, encoding a putative permease-related protein, is mutated in patients with lysinuric protein intolerance.
Borsani G; Bassi MT; Sperandeo MP; De Grandi A; Buoninconti A; Riboni M; Manzoni M; Incerti B; Pepe A; Andria G; Ballabio A; Sebastio G
Nat Genet; 1999 Mar; 21(3):297-301. PubMed ID: 10080183
[TBL] [Abstract][Full Text] [Related]
9. Imbalance of plasma amino acids, metabolites and lipids in patients with lysinuric protein intolerance (LPI).
Kurko J; Tringham M; Tanner L; Näntö-Salonen K; Vähä-Mäkilä M; Nygren H; Pöhö P; Lietzen N; Mattila I; Olkku A; Hyötyläinen T; Orešič M; Simell O; Niinikoski H; Mykkänen J
Metabolism; 2016 Sep; 65(9):1361-75. PubMed ID: 27506743
[TBL] [Abstract][Full Text] [Related]
10. Amino acid changes during successful pregnancy in a case of lysinuric protein insufficiency.
Osada H; Seki K
Gynecol Obstet Invest; 2006; 61(3):139-41. PubMed ID: 16374016
[TBL] [Abstract][Full Text] [Related]
11. Clinical and genetic features of lysinuric protein intolerance in Japan.
Noguchi A; Nakamura K; Murayama K; Yamamoto S; Komatsu H; Kizu R; Takayanagi M; Okuyama T; Endo F; Takasago Y; Shoji Y; Takahashi T
Pediatr Int; 2016 Oct; 58(10):979-983. PubMed ID: 26865117
[TBL] [Abstract][Full Text] [Related]
12. Lysinuric protein intolerance mutation is not expressed in the plasma membrane of erythrocytes.
Smith DW; Scriver CR; Simell O
Hum Genet; 1988 Dec; 80(4):395-6. PubMed ID: 3143662
[TBL] [Abstract][Full Text] [Related]
13. Impaired phagocytosis in macrophages from patients affected by lysinuric protein intolerance.
Barilli A; Rotoli BM; Visigalli R; Bussolati O; Gazzola GC; Gatti R; Dionisi-Vici C; Martinelli D; Goffredo BM; Font-Llitjós M; Mariani F; Luisetti M; Dall'Asta V
Mol Genet Metab; 2012 Apr; 105(4):585-9. PubMed ID: 22325938
[TBL] [Abstract][Full Text] [Related]
14. Skeletal manifestations of lysinuric protein intolerance. A follow-up study of 29 patients.
Svedström E; Parto K; Marttinen M; Virtama P; Simell O
Skeletal Radiol; 1993; 22(1):11-6. PubMed ID: 8430340
[TBL] [Abstract][Full Text] [Related]
15. Analysis of LPI-causing mutations on y+LAT1 function and localization.
Rotoli BM; Barilli A; Ingoglia F; Visigalli R; Bianchi MG; Ferrari F; Martinelli D; Dionisi-Vici C; Dall'Asta V
Orphanet J Rare Dis; 2019 Mar; 14(1):63. PubMed ID: 30832686
[TBL] [Abstract][Full Text] [Related]
16. Identification of SLC7A7, encoding y+LAT-1, as the lysinuric protein intolerance gene.
Torrents D; Mykkänen J; Pineda M; Feliubadaló L; Estévez R; de Cid R; Sanjurjo P; Zorzano A; Nunes V; Huoponen K; Reinikainen A; Simell O; Savontaus ML; Aula P; Palacín M
Nat Genet; 1999 Mar; 21(3):293-6. PubMed ID: 10080182
[TBL] [Abstract][Full Text] [Related]
17. Exploring the transcriptomic variation caused by the Finnish founder mutation of lysinuric protein intolerance (LPI).
Tringham M; Kurko J; Tanner L; Tuikkala J; Nevalainen OS; Niinikoski H; Näntö-Salonen K; Hietala M; Simell O; Mykkänen J
Mol Genet Metab; 2012 Mar; 105(3):408-15. PubMed ID: 22221392
[TBL] [Abstract][Full Text] [Related]
18. Oral supplementation corrects plasma lysine concentrations in lysinuric protein intolerance.
Lukkarinen M; Näntö-Salonen K; Pulkki K; Aalto M; Simell O
Metabolism; 2003 Jul; 52(7):935-8. PubMed ID: 12870174
[TBL] [Abstract][Full Text] [Related]
19. Necropsy findings in lysinuric protein intolerance.
McManus DT; Moore R; Hill CM; Rodgers C; Carson DJ; Love AH
J Clin Pathol; 1996 Apr; 49(4):345-7. PubMed ID: 8655715
[TBL] [Abstract][Full Text] [Related]
20. Nutrient intake in lysinuric protein intolerance.
Tanner LM; Näntö-Salonen K; Venetoklis J; Kotilainen S; Niinikoski H; Huoponen K; Simell O
J Inherit Metab Dis; 2007 Oct; 30(5):716-21. PubMed ID: 17588131
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
